Publications about TBS More than 1200 publications about TBS Search through Publications Keywords, Titles, Tags, AuthorsSearch Filter by TagsAll1.19 (0.99-1.43)200 MOF were recorded. Fractured women were older25-Hydroxy vitamin D;3d dxaAbaloparatideAcromegalyAdalimumabAdolescentADPKD had a similar BMD and lower T-score compared to non-ADPKD [BMD: 1.120 vs. 1.126ADPKD is caused by pathogenic variants in PKD1 or PKD2Adrenal incidentalomaadrenalectomyAfrican Americansafter adjustment for FRAX-CRFAiAlcoholAlcoholic liver diseaseAldosteroneAlendronateALSAmphetaminesamytrophicAnabolic drugsand 1.52 (1.26-1.84)and loss of function is associated with low bone mineral density (BMD) and volume. Howeverand stiffness index (SI))and TBS. Thusand TBS. We found no association between the change of QUS parameters in 2.5 years and incident MOF. Conclusion: Heel-QUS predicts fracture independently of FRAXand TBS; higher FRAX-CRF risk; and more prevalent fractures. TBS was significantly correlated with SOS (0.409) and SI (0.472). A decrease of one SD in SIAnkylosing SpondylitisAnorexiaAnti-resorptive treatmentAntiresorptive therapyAntiretroviral therapyAntiretroviral therapy (ART)ArgentinaAromatase inhibitorArtificial Intelligenceasian raceasthmaAustraliaAustriaAxial spondyloarthritisBariatricBelgiumBeta-thalassemiaBiomimetic MaterialsBiphosphonatesBisphosphonateBisphosphonatesBlood transfusionBMDBMIBody compositionbody mass indexbody mass index (BMI; p = 0.001)Bone densityBone diseasesbone fragilityBone geometryBone marrow fatBone metabolic diseasesBone microarchitectureBone mineral densityBone mineral density (BMD)bone qctBone SubstitutesBone turnover markersBonesBowel diseaseBrazilBreast cancerBUABUA or SOS increased the MOF risk by (OR(95%CI)) 1.43 (1.18-1.75)BulgariaC-reactive proteinCalcitoninCalciumCanadaCancellous boneCancerCardiovascularCardiovascular eventsCase reportChileChinaChinese AmericanChinese populationChronic inflammationChronic kidney disease-mineral and bone disorderClinical trialsconfirmatory factor analysisCOPDCorrectioncorticosteroidCortisolCrohn's diseaseCushing SyndromeCushing's syndromecystic fibrosisCzech RepublicDegenerative diseaseDenmarkDenosumabDensitometryDiabetesDiabetes mellitusDiabetes mellitus type 2DiagnosisDialysisDietDiffuse idiopathic skeletal hyperostosisDown syndromeDual X-RayDual-energy X-ray absorptiometryDXADXA (BMD and TBS)EgyptEhlers-Danlos syndromeencoding polycystin-1 and -2 proteins. Polycystins are expressed in osteoblasts and chondrocytes in animal modelsEnd stage renal diseaseEndocrine disordersEndocrinologyEndometriosisEOSEstrogenEthnicityExemestaneExercise trainingfailure loadfat mass index (FMI; p < 0.001)Femalefemoral neck and total hipFibromalgiaFinite Elements AnalysisFinlandFractureFracture predictionFracture riskFracture Risk Assessment ToolFracturesfragility fractureFrailtyFranceFRAXGastric bypassGastritisGaucher diseaseGE-LunarGenetic factorsGermanyGlucocorticoidsGlucose metabolismGraves' diseaseGreeceGrowth hormoneGrowth hormone-secreting pituitary adenomaGuidelineGuidelinesHaemophiliaHDLHeart failureheel quantitative ultrasoundHemodialysisHepatic cirrhosisHepatitis CHIVHologicHormone replacement therapyHR-pQCTHuman immunodeficiency virusHypercortisolismHyperparathyroidismHyperthyroidismHypogonadismHypoparathyroidismHypophosphatasiaHypopituitarismIbandronateimmunityincidentalomaIndiaInsulin resistanceIranIrelandISCDit is unclear whether these variants impact bone strength in ADPKD patients. HereItalyJapanKidney diseaseKlinefelter syndromeKneeLean tissue massLebanonLetterlipid metabolismLipid profile-dyslipidemiaLipodystrophyLiverLong-term careLongitudinallumbar spinelung transplantationMaleMeeting reportMenMeta-analysisMetablic syndromeMetabolic syndromeMexicoMicroarchitectureMicroindentationmicroRNAMineral metabolismMonoclonal gammopathymore treated with anti-osteoporosis medication; had lower QUSMortalityMRIMultiple myelomaMultiple sclerosisMuscle strengthMuscle weaknessMuscular strenghtMuscular strengthNetherlandsNeurofibromatosisNeurologyNormative dataNorwayObesityObstructive pulmonary diseaseObstructive Sleep ApneaOdanacatibOmega-3OrbitopathyOsteoarthritisOsteogenesis imperfectaOsteoporosisOsteosarcopeniap < 0.001; T-score: -0.60 vs. -1.08p < 0.001; T-score: -0.62 vs. -0.99p < 0.001; T-score: -1.16 vs. -1.46p < 0.001]p < 0.001] and at left TH [BMD: 0.960 vs. 0.893p = 0.001; T-score: -1.20 vs. -1.41p = 0.001]. At the LS levelp = 0.008]. After adjusting for preemptive KTxp = 0.01] and at left FN [BMD: 0.885 vs. 0.840p = 0.93; T-score: -0.66 vs. -0.23paget's diseaseParkinsonPeak bone massPediatricsPentosidinePerceived agePhantomPhenylketonuriaPheochromocytomaPhysical activityPhysical performancePolandPolymyalgia rheumaticaPortugalpositivePost-menopausal osteoporosis;Postmenopausal womenPostmenopausepQCTPrednisonePregnancyPrimary hyperparathyroidismProstate cancerProton pump inhibitorsPsoriasisPTHPulmonaryPulmonary diseasesQuantitative ultrasoundQUS represents an important case finding/pre-screening tool in osteoporosis management. The change in QUS over time was not associated with future fracturesRaloxifenerange 18-64) with 47Rare bone diseaseReference datarespectivelyrespectively. Similar results were found at the right femoral neck (FN) between ADPKD and non-ADPKD [BMD: 0.887 vs. 0.848ReviewRheumatoid arthritisRheumatologyRisedronaterisk assessmentRomaniaRomosozumabRunnersRussiaSafetySarcopeniaSclerostinSecondary osteoporosissecondary osteoporosis; bone mineral density; dual-energy X-ray absorptiometry (DXA); trabecular bone score/TBS; fragility fractureSensitivity and SpecificitySerbiaShort statureSlovakiaSloveniaSmokersSoft tissueSoft tissue thicknessSouth AfricaSouth KoreaSpainSpinal chord injurySpinal fracturesSpine SurgerySpondyloarthritisSportsStem cell transplantSteroidsstructural equation modelingSwedenSwitzerlandSympathetic activitySystemic sclerosisT1DMTaiwanTamoxifenTBSTBS and body composition. Prevalence of VFs was assessed by quantitative morphometry on lateral spine X-rays. Results: VFs were detected in 14 patients (19.7%)TBS Osteo - All publications about FRAXTBS-adjusted FRAXTechnical studyTechnical variabilityTenofovir disoproxil fumarateTeriparatideTestosteroneThailandThe NetherlandsThis study aimed to better define the role of heel-QUS in fracture prediction. Our results showed that heel-QUS predicts fracture independently of FRAXThyroidThyroidectomyThyroxineTotal Knee Arthroplasty (TKA)Total knee replacementTrabecular bone scoreTrabecular bone score (TBS)Trabecular bone score TBS Fracture Osteoporosis GuidelinesTransgenderTransplantTransplantationtreatmentTreatment (anti-osteoporotic treatments)TSECTSH suppressive therapytumorTurkeyTurner syndromeType 2 diabetes mellitusTyrotropin suppressive therapyUKUkraineUlcerative colitisUSAVertebral fracturesvertebral fractures (VFs) and trabecular bone score (TBS) in adult subjects with KS. Methods: Seventy-one adult males (median age 41 yearsVertebral Fragility FracturesVFs were significantly associated with truncal/leg fat ratio (OR 2.32 per tertile; 95% CI 1.05-5.15; p = 0.038)VietnamVitamin DVO2waist circumference (p = 0.007)we evaluated the associations between body composition parametersWeight reduction programswhereas impaired TBS (detected in 23.4% of subjects) was associated with older age at study entry (p = 0.001) and at diagnosis of disease (p = 0.015)without significant association with low BMD (p = 0.912). In univariate logistic regression analysisX-linked hypophosphatemic ricketsYoung AdultZoledronate Trabecular bone score in healthy ageing Authors: Bazzocchi, A.; Ponti, F.; Diano, D.; Amadori, M.; Albisinni, U.; Battista, G.; Guglielmi, G. Year: 2015 PubMed Link Tags: GE-Lunar, Italy, Reference data, See Details » Treatment of Vitamin D Insufficiency in Postmenopausal Women: A Randomized Clinical Trial. Authors: Hansen, Karen E.; Johnson, R. Erin; Chambers, Kaitlin R.; Johnson, Michael G.; Lemon, Christina C.; Vo, Tien Nguyen Thuy; Marvdashti, Sheeva Year: 2015 PubMed Link Tags: GE-Lunar, Longitudinal, Treatment (anti-osteoporotic treatments), USA, Vitamin D, See Details » Choosing the tool for osteoporosis risk prediction Authors: Cormier, Catherine; Koumakis, Eugenie; Souberbielle, Jean-Claude Year: 2015 PubMed Link Tags: Osteoporosis, Review, See Details » Executive Summary of the 2015 ISCD Position Development Conference on Advanced Measures From DXA and QCT: Fracture Prediction Beyond BMD Authors: Shepherd, John A.; Schousboe, John T.; Broy, Susan B.; Engelke, Klaus; Leslie, William D. Year: 2015 PubMed Link Tags: Guidelines, ISCD, Osteoporosis, Review, See Details » Fracture Risk Prediction by Non-BMD DXA Measures: the 2015 ISCD Official Positions Part 2: Trabecular Bone Score. Authors: Silva, Barbara C.; Broy, Susan B.; Boutroy, Stephanie; Schousboe, John T.; Shepherd, John A.; Leslie, William D. Year: 2015 PubMed Link Tags: Guidelines, ISCD, Osteoporosis, Review, TBS Osteo - All publications about FRAX, See Details » Association between long-term exercise loading and lumbar spine trabecular bone score (TBS) in different exercise loading groups Authors: Heiniö, L.; Nikander, R.; Sievänen, H. Year: 2015 PubMed Link Tags: Finland, GE-Lunar, Physical activity, Runners, Sports, Young Adult, See Details » Perceived age is associated with bone status in women aged 25-93 years Authors: Nielsen, Barbara Rubek; Linneberg, Allan; Christensen, Kaare; Schwarz, Peter Year: 2015 PubMed Link Tags: Denmark, Hologic, Osteoporosis, Perceived age, See Details » [Diagnosing osteoporosis: what is new in the 2014 DVO guideline?] Authors: Pfeilschifter, Johannes Year: 2015 PubMed Link Tags: Germany, Guidelines, Osteoporosis, Review, See Details » Insights on accelerated skeletal repair in Cushing’s disease Authors: Kim, So-Young; Davydov, Oksana; Hans, Didier; Bockman, Richard Year: 2015 PubMed Link Tags: Case report, Cushing Syndrome, Endocrinology, GE-Lunar, Glucocorticoids, Longitudinal, Secondary osteoporosis, Treatment (anti-osteoporotic treatments), USA, See Details » Effects of Exemestane and Tamoxifen treatment on bone texture analysis assessed by TBS in comparison with bone mineral density assessed by DXA in women with breast cancer Authors: Kalder, Matthias; Hans, Didier; Kyvernitakis, Ioannis; Lamy, Olivier; Bauer, Martina; Hadji, Peyman Year: 2014 PubMed Link Tags: Aromatase inhibitor, Breast cancer, Cancer, Exemestane, GE-Lunar, Germany, Longitudinal, Secondary osteoporosis, Tamoxifen, Treatment (anti-osteoporotic treatments), See Details » ‹ 1 … 54 55 56 57 58 … 63 ›
